Organon, LLC
Pharmaceutical Company.
Based in DC
AI Overview
With $1.0M in lobbying spend across 20 quarterly filings, Organon, LLC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $120K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Organon, LLC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid
Issues related to womens health and drug pricing.
Issues related to pharmaceuticals and women's health.
Issues related to drug pricing, reimbursement for prescription drugs; S. Con Res 14; Issues related to women's health; Issues related to HHS Comprehensive Plan for Addressing High Drug Prices: A Repor
Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act; Issues related to the American Families Plan; S. Con Res 14; Issues related to wom
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.